Baillie Gifford - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 56 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,070,000
-8.9%
436,5120.0%0.00%0.0%
Q4 2021$1,174,000
-46.3%
436,5120.0%0.00%0.0%
Q3 2021$2,187,000
-32.8%
436,5120.0%0.00%
-50.0%
Q2 2021$3,256,000
+49.0%
436,512
+17.3%
0.00%
+100.0%
Q1 2021$2,185,000
+24.9%
372,2610.0%0.00%0.0%
Q4 2020$1,749,000
+36.5%
372,2610.0%0.00%0.0%
Q3 2020$1,281,000372,2610.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders